December 19, 2007 - Abiomed Inc. today announced that it has received approval from the FDA for U.S. commercial ...
Ventricular Assist Devices (VAD)
This channel includes news and new technology innovations for ventricular assist devices (VAD). VADs are a type of mechanical hemodynamic support device that helps increase blood flow in people who have ventricles that are not work properly due to heart failure, cardiogenic shock, cardiomyopathy or myocardial infarction. Most often these devices support the left ventricle, so they are often referred to as left ventricular assist devices (LVAD). VADS come in two types, surgically implanted, usually as a bridge to heart transplant, and percutanenous catheter-based pumps used for temporary hemodynamic support. Examples of temporary percutaneous pumps include the Impella and TandemHeart devices.
December 13, 2007 - World Heart Corp., a developer of implantable mechanical circulatory support systems for ...
December 12, 2007
December 13, 2007 - The American Red Cross and the American Heart Association join in thanking Congress today for ...
December 12, 2007December 4, 2007- Berlin Heart announced the first patient enrollment in the prospective IDE study for its EXCOR ...
December 03, 2007November 21, 2007 - Ventracor announced 10 U.S. hospitals have implanted at least one VentrAssist left ventricular ...
November 20, 2007
CircuLite Inc. reported the launch of the clinical development program for its Synergy Pocket Circulatory Assist ...
November 14, 2007
Feature | Richard R. Rogoski
A study published in 2002, which assigned a 0-5 score to various clinical parameters, is still considered a major ...
November 13, 2007November 4, 2007 - A small, implantable device that helps the heart pump blood works equally well for men and women but ...
November 03, 2007October 25, 2007 - Abiomed Inc. announced for the first time, at TCT 2007, that the Impella 2.5 PROTECT I safety trial ...
October 24, 2007October 16, 2007 - Abiomed Inc. will be presenting clinical data on Impella 2.5 percutaneous Ventricular Assist Device ...
October 15, 2007September 18, 2007 - The DuraHeart Left Ventricular Assist System (LVAS) reported a survival rate of 77 percent for all ...
September 17, 2007August 30, 2007 - Abiomed Inc. announced it has received conditional approval from the FDA to begin its pivotal clinical ...
August 29, 2007August 30, 2007 - Concentric Medical announces that it has obtained FDA 510(k) clearance for its Merci L6 Retriever, a ...
August 29, 2007August 15, 2007 - Thoratec Corp., a world leader in products to treat cardiovascular disease, said today that its ...
August 14, 2007Aug. 9, 2007 - Abiomed Inc. today announced financial results for its first quarter of fiscal 2008 with record revenue ...
August 08, 2007© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now